Added value of ctDNA testing with primary treatment for metastatic prostate cancer prognosis
Crossref DOI link: https://doi.org/10.1038/s43018-026-01176-5
Published Online: 2026-05-26
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining valid from 2026-05-26
Version of Record valid from 2026-05-26
Article History
First Online: 26 May 2026